About CytoTronics
CytoTronics is a company based in Boston (United States) founded in 2015 by Vince Wu.. CytoTronics has raised $22.75 million across 2 funding rounds from investors including Anzu Partners and Milad Alucozai. The company has 22 employees as of December 31, 2024. CytoTronics offers products and services including Pixel and Cloud-Based Software. CytoTronics operates in a competitive market with competitors including Kiyatec, Cellply, Lucid Scientific, DiscoverX and Saguaro, among others.
- Headquarter Boston, United States
- Employees 22 as on 31 Dec, 2024
- Founders Vince Wu
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cytotronics, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$22.75 M (USD)
in 2 rounds
-
Latest Funding Round
$13.5 M (USD), Series A
Mar 22, 2024
-
Investors
Anzu Partners
& 1 more
-
Employee Count
22
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CytoTronics
CytoTronics offers a comprehensive portfolio of products and services, including Pixel and Cloud-Based Software. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Enables monitoring of live-cell functions for biological research applications.
Facilitates quick analysis of live-cell measurements for cellular insights.
Unlock access to complete
Unlock access to complete
Funding Insights of CytoTronics
CytoTronics has successfully raised a total of $22.75M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $13.5 million completed in March 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $13.5M
-
First Round
First Round
(28 Apr 2022)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2024 | Amount | Series A - CytoTronics | Valuation |
investors |
|
| Apr, 2022 | Amount | Seed - CytoTronics | Valuation | Anzu Partners |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in CytoTronics
CytoTronics has secured backing from 2 investors, including venture fund and angel investors. Prominent investors backing the company include Anzu Partners and Milad Alucozai. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made in industrial and life sciences technology companies.
|
Founded Year | Domain | Location | |
|
MA
Milad Alucozai |
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by CytoTronics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - CytoTronics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cytotronics Comparisons
Competitors of CytoTronics
CytoTronics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kiyatec, Cellply, Lucid Scientific, DiscoverX and Saguaro, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Kiyatec is focused on revolutionizing cancer care through predictive platforms.
|
|
| domain | founded_year | HQ Location |
Developer of in-vitro diagnostic products for the detection of cancer
|
|
| domain | founded_year | HQ Location |
Real-time cell analyzers are developed for oxygen consumption monitoring.
|
|
| domain | founded_year | HQ Location |
Develops cell-based assays and provides services for drug discovery and development.
|
|
| domain | founded_year | HQ Location |
3D cell culture products are developed for drug discovery applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cytotronics
Frequently Asked Questions about CytoTronics
When was CytoTronics founded?
CytoTronics was founded in 2015 and raised its 1st funding round 7 years after it was founded.
Where is CytoTronics located?
CytoTronics is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Is CytoTronics a funded company?
CytoTronics is a funded company, having raised a total of $22.75M across 2 funding rounds to date. The company's 1st funding round was a Seed of $9.25M, raised on Apr 28, 2022.
How many employees does CytoTronics have?
As of Dec 31, 2024, the latest employee count at CytoTronics is 22.
What does CytoTronics do?
CytoTronics was founded in 2015 in Boston, United States, and operates in the biotechnology sector focused on drug discovery. Cell-based assays are enabled through a CMOS electronics platform, which measures and manipulates live cells for real-time, high-resolution electrical and electrochemical analysis. Optics-free imaging is facilitated, supporting applications in pharmaceutical research and development.
Who are the top competitors of CytoTronics?
CytoTronics's top competitors include Kiyatec, Remedy Plan and Indigo Biosciences.
What products or services does CytoTronics offer?
CytoTronics offers Pixel and Cloud-Based Software.
Who are CytoTronics's investors?
CytoTronics has 2 investors. Key investors include Anzu Partners, and Milad Alucozai.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.